Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.067 | 0.7 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |